Preimplantation Genetic Testing Market Size 2025 And Growth Rate

The preimplantation genetic testing market size has grown rapidly in recent years. It will grow from $0.83 billion in 2024 to $0.92 billion in 2025 at a compound annual growth rate (CAGR) of 11.6%. The growth in the historic period can be attributed to increasing incidence of genetic disorders, growing awareness of genetic testing, increase in prenatal testing options, growing demand for personalized medicine, and increasing focus on preventive healthcare.

Preimplantation Genetic Testing Market Growth Forecast

The preimplantation genetic testing market size is expected to see rapid growth in the next few years. It will grow to $1.41 billion in 2029 at a compound annual growth rate (CAGR) of 11.2%. The growth in the forecast period can be attributed to the rising number of fertility clinics, growth in genetic counseling services, growing prevalence of advanced maternal age, increasing availability of advanced genetic testing platforms, and expanding applications of PGT. Major trends in the forecast period include the adoption of advanced sequencing technologies, implementation of expanded genetic panels, development of non-invasive testing methods, advancements in embryo culture systems, and advancements in genetic editing technologies.

Preimplantation Genetic Testing Market Driver: Growth In IVF Procedures Driving Preimplantation Genetic Testing Market Expansion

The increase in in vitro fertilization (IVF) procedures is expected to propel the growth of the preimplantation genetic testing market going forward. IVF procedures consist of fertilizing an egg with sperm outside the body to form an embryo, which is subsequently placed in the uterus. The growth in IVF procedures is driven by improvements in reproductive technology, increasing infertility rates, and heightened public awareness. The rise in in vitro fertilization (IVF) procedures is boosting the preimplantation genetic testing market by increasing the demand for genetic screening of embryos before implantation. For instance, in April 2024, according to the Society for Assisted Reproductive Technology, a US-based organization, in 2022, 91,771 babies were born through in vitro fertilization (IVF). Therefore, the increase in in vitro fertilization (IVF) procedures is driving the preimplantation genetic testing market.

Global Preimplantation Genetic Testing Market Major Players

Major companies operating in the preimplantation genetic testing market are Thermo Fisher Scientific, Abbott Laboratories, Laboratory Corporation of America Holdings, Agilent Technologies Inc., Illumina Inc., Revvity Health Science Inc., CooperSurgical Inc., Natera Inc., Progyny Inc., Myriad Genetics Inc., Fulgent Genetics Inc., Invitae Corporation, Takara Bio Inc., MedGenome Labs Ltd., Genea Limited, Ovation Fertility, Juno Genetics Ltd., Invicta Genetics, Progenesis, Bioarray SL, PacGenomics, Reproductive Genetic Innovations LLC, SEQUENCE46 LLC

Global Preimplantation Genetic Testing Market Trend: Advanced NGS Tools Enhance Accuracy And Efficiency In Preimplantation Genetic Testing

Major companies operating in the preimplantation genetic testing market are developing advanced next-generation sequencing (NGS) tools to enhance accuracy, efficiency, and speed in genetic screening, enabling more comprehensive analysis and better-informed decisions for prospective parents. Next-generation sequencing (NGS) tools accelerate genetic research with rapid, high-throughput analysis of deoxyribonucleic acid (DNA) and ribonucleic acid (RNA). They provide detailed insights into genetic variations and gene expression, improving accuracy and enabling personalized medicine. For instance, in July 2023, Thermo Fisher Scientific, a US-based biotechnology company, launched the Ion ReproSeq PGT-A Kit and the Ion AmpliSeq Polyploidy Kit, advanced next-generation sequencing tools designed to enhance IVF and ICSI research. These assays streamline workflows from sample processing to aneuploidy analysis with cutting-edge technology on the ion torrent genexus integrated sequencer, marking a significant advancement in the preimplantation genetic testing market by enhancing embryo screening and improving success rates in assisted reproductive technologies.

Preimplantation Genetic Testing Market Merger And Acquisition: Kindbody Strengthens Fertility Services With Acquisition Of Phosphorus Labs

In June 2022, Kindbody, a US-based company that provides fertility and wellness services, acquired a Genomics Company, Phosphorus Labs, for an undisclosed amount. The acquisition of Phosphorus Labs allows Kindbody to integrate genetic testing capabilities into its fertility services, enhancing patient care through personalized treatment plans. Phosphorus Labs is a US-based provider of preimplantation genetic testing.

Regional Outlook For The Global Preimplantation Genetic Testing Market

North America was the largest region in the preimplantation genetic testing market in 2024. Asia-Pacific is expected to be the fastest-growing region in the forecast period. The regions covered in the preimplantation genetic testing market report are Asia-Pacific, Western Europe, Eastern Europe, North America, South America, Middle East, Africa.

The countries covered in the preimplantation genetic testing market report are Australia, Brazil, China, France, Germany, India, Indonesia, Japan, Russia, South Korea, UK, USA, Canada, Italy, Spain.

What Defines the Preimplantation Genetic Testing Market?

The preimplantation genetic testing (PGT) market consists of revenues earned by entities by providing services such as data analysis tools, genetic counseling, cloud-based platforms, and embryo selection algorithms. The market value includes the value of related goods sold by the service provider or included within the service offering. The preimplantation genetic testing (PGT) market also includes sales of genetic testing (PGT) kits, next-generation sequencers, and polymerase chain reaction (PCR) machines. Values in this market are ‘factory gate’ values, that is, the value of goods sold by the manufacturers or creators of the goods, whether to other entities (including downstream manufacturers, wholesalers, distributors, and retailers) or directly to end customers. The value of goods in this market includes related services sold by the creators of the goods.

How is Market Value Defined and Measured?

The market value is defined as the revenues that enterprises gain from the sale of goods and/or services within the specified market and geography through sales, grants, or donations in terms of the currency (in USD, unless otherwise specified).

The revenues for a specified geography are consumption values that are revenues generated by organizations in the specified geography within the market, irrespective of where they are produced. It does not include revenues from resales along the supply chain, either further along the supply chain or as part of other products.

What is the Market Assessment and Strategic Outlook for the Preimplantation Genetic Testing Industry?

The preimplantation genetic testing market research report is one of a series of new reports from The Business Research Company that provides preimplantation genetic testing market statistics, including preimplantation genetic testing industry global market size, regional shares, competitors with a preimplantation genetic testing market share, detailed preimplantation genetic testing market segments, market trends and opportunities, and any further data you may need to thrive in the preimplantation genetic testing industry. This preimplantation genetic testing market research report delivers a complete perspective on everything you need, with an in-depth analysis of the current and future scenarios of the industry.